OneCell Diagnostics is a genomics-based precision oncology company, providing comprehensive genomic solutions for better cancer management. OneCell's proprietary technology leverages a combination of next-generation sequencing in combination with strong bioinformatics, AI / ML, and data-analytics for multi-omics biomarkers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/21/24 | $16,000,000 | Series A |
Cedars-Sinai Medical Center Celesta Capital  Eragon Singularity Ventures Tenacity Venture Capital | undisclosed |
